Cargando…
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
BACKGROUND: The new emerging avian influenza A H7N9 virus, causing severe human infection with a mortality rate of around 41%. This study aims to provide a novel treatment option for the prevention and control of H7N9. METHODS: H7 hemagglutinin (HA)-specific B cells were isolated from peripheral blo...
Autores principales: | Li, Jingxin, Zhang, Li, Bao, Linlin, Wang, Yuxiao, Qiu, Lin, Hu, Jialei, Tang, Rong, Yu, Huiyan, Shan, Jun, Li, Yan, Qin, Chuan, Zhu, Fengcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276153/ https://www.ncbi.nlm.nih.gov/pubmed/35671181 http://dx.doi.org/10.1097/CM9.0000000000002001 |
Ejemplares similares
-
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019) -
Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus
por: Wang, Yanan, et al.
Publicado: (2022) -
Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022) -
In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity
por: Wu, Nicholas C., et al.
Publicado: (2017) -
Production of highly and broad-range specific monoclonal antibodies against hemagglutinin of H5-subtype avian influenza viruses and their differentiation by mass spectrometry
por: Sączyńska, Violetta, et al.
Publicado: (2018)